Are GLP-1s the First Longevity Drugs — or Just the First Big Proxy?
Few drug classes have moved from endocrinology into so many neighboring territories so quickly. What began as a diabetes story […]
From 9 to 12 Hallmarks: The Aging Framework That Now Shapes Longevity Science
For a field obsessed with complexity, longevity science has an unusual attachment to one simple idea: aging can be organized